about
Prevention of Obesity and DiabetesScreening for and managing diabetic retinopathy: current approachesAmerican association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015Blood pressure and diabetic nephropathyNeuropathy, retinopathy, and glucose-lowering treatments.The clinical approach to the detection of lipodystrophy - an AACE consensus statementAmerican Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations.The American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension.Neuropathy, womens' health, and socioeconomic aspects of diabetes.Diabetes treatment and cardiovascular safetyObesity, hypertension, and insulin resistance.Adiposity and diabetes.Is haemoglobin A1c a step forward for diagnosing diabetes?Nonnutritive sweeteners, fructose, and other aspects of diet.American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.Inflammation and insulin resistance.World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 2World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 3.Diabetes issues in women and children: polycystic ovary syndrome.World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 4.Approaches to cardiovascular disease and its treatment.Aspects of blood pressure, lipid, and glycemic treatment.Type 2 diabetes in the young: the evolving epidemic.Glycemic treatment: Control of glycemia.Diabetes complications.Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.Consequences of diabetes: cardiovascular disease.Inpatient diabetes control: rationale.Inpatient diabetes control: approaches to treatment.Gut-derived incretin hormones and new therapeutic approaches.Diet and diabetes.Dyslipidemia and the metabolic syndrome.Transplantation and islet topics.Diabetic retinopathy and neuropathy.Inflammation, atherosclerosis, and aspects of insulin action.Insulin resistance: causes and consequences.2nd International Symposium on triglycerides and HDL: metabolic syndrome.Developments in diabetes and insulin resistance.
P50
Q22241281-06BDBED8-218F-451B-9A2D-14F0A2EA5954Q28220190-A0597F17-7317-46AA-B305-672618B4EBC0Q28384855-F72ECA07-37A5-467B-8CF3-EAC3A6C30EA5Q33683851-C0C6A98F-A800-4C73-999A-A0E5173F2482Q33873262-09C2F5A8-782C-4D74-B49A-BD9D63A38620Q33939518-3F94F202-7DBC-46F0-8696-E7F26B7352C3Q34081331-82840055-AE27-4164-B21A-2C750DA0D5E3Q34323633-A0530509-3DCF-4B6C-8026-8022732EF237Q34421903-BCA9E83E-ED49-4961-997A-EC243BC7B40EQ34567732-678FFAA8-F562-4636-B498-AE9A955A7047Q34658084-9B6499D2-FC87-4A5A-931E-D5372AE69731Q34718512-86D3C5CE-8718-487D-88EF-8B853AE444D9Q34981094-EEA07F77-40DA-462A-B749-7BB5A061791EQ35009868-A46DC8D4-CD7A-4CA2-B418-360770822E83Q35012219-7AF9C1CE-17B4-482C-AF49-B2A02F474B95Q35043802-28815379-DDC4-46C2-A87D-ED56C9700558Q35074681-BA1CAE23-1D25-4F3A-B256-A919B15FD96AQ35115560-DA4E5488-0893-46E1-9722-5E825C6B6BE8Q35123374-C89F8207-BEE4-4CBF-A5AB-72FC0BED2F8FQ35179847-233B02B8-A08D-44D5-A86A-ACE56297C3EEQ35185836-5A756E6C-F000-4BF4-B330-FA9372698641Q35225508-8A75CE50-950A-49BC-A39D-6219E5ACE1BCQ35591506-96DF7BC7-28E6-43A5-8881-BC5D5EF023C3Q35615577-1AE778DC-D9A5-4293-BD90-241BA4A274F4Q35718812-EA8AAC2A-2426-489A-8B45-6ED2B07B276FQ35757479-68800E53-714B-49E6-BD68-1DAE514AF743Q35783130-C59DB0C1-0D06-4607-B254-1F2AED6D058EQ35818993-3CDCEDAD-18EB-4F24-83C3-56C836846724Q35819004-87F0C654-5D1A-4F67-A132-1B7ED685CE4CQ35847378-4B057A83-6A16-464B-9B61-3DA298D5EC5AQ35873048-5355AF66-FF95-4D12-AD8E-7E4A9EFF0C09Q35903418-BF76FB6B-DB18-4166-B9AF-7351175660BCQ35927763-BF3B5090-70E3-463D-8FCE-5EAB6EAF88F3Q35962071-4AB0185C-8284-41B5-A406-978ED5439EB1Q35992362-370679AA-861E-453D-8130-FC5CB240601CQ36081319-DE7EF0D8-C862-4A61-9EC3-FD0D0AA39001Q36241125-AF7A4E13-534B-4526-B661-233E107E3F1AQ36248033-86997648-CE14-48C9-A630-EF8BEEDA3A64Q36269045-D4C7CF4A-31A9-4A8E-8B75-1E27D6264A5DQ36351126-76E7D827-C857-4F92-9804-CA2D146AAB45
P50
name
Zachary T Bloomgarden
@ast
Zachary T Bloomgarden
@en
Zachary T Bloomgarden
@nl
type
label
Zachary T Bloomgarden
@ast
Zachary T Bloomgarden
@en
Zachary T Bloomgarden
@nl
prefLabel
Zachary T Bloomgarden
@ast
Zachary T Bloomgarden
@en
Zachary T Bloomgarden
@nl